Cargando…
Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination
Demyelinating diseases, such as multiple sclerosis, are characterized by inflammatory demyelination and neurodegeneration of the central nervous system. Therapeutic strategies that induce effective neuroprotection and enhance intrinsic repair mechanisms are central goals for future therapy of multip...
Autores principales: | Crawford, Daniel K., Mangiardi, Mario, Song, Bingbing, Patel, Rhusheet, Du, Sienmi, Sofroniew, Michael V., Voskuhl, Rhonda R., Tiwari-Woodruff, Seema K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947430/ https://www.ncbi.nlm.nih.gov/pubmed/20858739 http://dx.doi.org/10.1093/brain/awq237 |
Ejemplares similares
-
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)
por: Gold, Stefan M, et al.
Publicado: (2009) -
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis
por: Moore, Spencer, et al.
Publicado: (2013) -
Oestrogen receptor β ligand acts on CD11c(+) cells to mediate protection in experimental autoimmune encephalomyelitis
por: Kim, Roy Y, et al.
Publicado: (2018) -
A role for sex chromosome complement in the female bias in autoimmune disease
por: Smith-Bouvier, Deborah L., et al.
Publicado: (2008) -
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis
por: Karim, Hawra, et al.
Publicado: (2019)